SCHEMBL8976249

SCHEMBL8976249

COc1cc2ncnc(Nc3cccc4c3CCCC4)c2cc1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.65
RET P07949 11/20 0.61
KDR P35968 7/20 0.61
KIF5B P33176 6/20 0.61
FLT1 P17948 1/20 0.61
LCK P06239 2/20 0.60
KDM4E B2RXH2 1/20 0.57
GAK O14976 1/20 0.57
MAPK13 O15264 1/20 0.57
ABL1 P00519 1/20 0.57
ERBB2 P04626 1/20 0.57
CYP1A2 P05177 1/20 0.57
CDK1 P06493 1/20 0.57
CYP3A4 P08684 1/20 0.57
FBP1 P09467 1/20 0.57
CYP2D6 P10635 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
SRC P12931 1/20 0.57
TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8583372 0.99 EGFR (0.64) EGFRRETKDRKIF5BFLT1
SCHEMBL2286956 0.86 EGFR (0.56) EGFRRETKDRKIF5BFLT1
SCHEMBL30264393 0.82 EGFR (0.53) EGFRERBB2SRC
SCHEMBL30264288 0.80 EGFR (0.72) EGFRRETERBB2EPHB2
SCHEMBL30264685 0.80 EGFR (0.53) EGFRERBB2SRC
SCHEMBL30264479 0.80 EGFR (0.48) EGFRRETKDRKIF5BLCK
SCHEMBL12200787 0.79 RET (0.74) EGFRRETKDRKIF5BFLT1
SCHEMBL31747062 0.78 RET (0.74) EGFRRETKDRKIF5BFLT1
SCHEMBL4447123 0.78 SRC (0.68) EGFRGAKABL1ERBB2SRC
SCHEMBL18158498 0.78 EGFR (0.62) EGFRRETKDRFLT1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1100540-C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties AVENTIS PHARMA INC (US) 2003-02-05 CN disclosed
CN-1187129-A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties RHONE POULENC RORER PHARMA (US) 1998-07-08 CN disclosed
US-5580870-A ANTICARCINOGENIC AGENTS ZENECA LIMITED (GB) 1996-12-03 US disclosed
EP-0602851-B1 Quinazoline derivatives ZENECA LTD (GB) 1996-10-09 EP disclosed
CN-1094043-A Quinazoline derivant ZENECA LTD (GB) 1994-10-26 CN disclosed
EP-0602851-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1994-06-22 EP disclosed